Methocarbamol 20mL

Description

Adjunct therapy for acute inflammatory and traumatic conditions of the skeletal muscle and to reduce muscular spasms.
Dogs, cats: Efficacy of methocarbamol in the treatment of acute skeletal muscle hyperactivity secondary to the following conditions has been reported: intervertebral disc syndrome, compressive myelitis, spinal cord injury when cord remains intact, trauma causing muscular and ligamentous sprains and strains, myositis, fibrositis, bursitis and synovitis, muscular spasm prior to or following surgical procedures.
Horses: Methocarbamol Injection is indicated as an adjunct therapy for acute inflammatory and traumatic conditions of the skeletal muscle, to reduce muscular spasms, and effect striated muscle relaxation.
Efficacy of methocarbamol in the treatment of acute muscle hyperactivity secondary to the following conditions has been reported: trauma, muscular and ligamentous sprains and strains, myositis, fibrositis, bursitis and synovitis, tying up syndrome, muscular spasm prior to or following surgical procedures and maintenance of muscle relaxation in tetanus.

Product Information

Adjunct therapy for acute inflammatory and traumatic conditions of the skeletal muscle and to reduce muscular spasms.
Dogs, cats. Efficacy of methocarbamol in the treatment of acute skeletal muscle hyperactivity secondary to the following conditions has been reported: intervertebral disc syndrome, compressive myelitis, spinal cord injury when cord remains intact, trauma causing muscular and ligamentous sprains and strains, myositis, fibrositis, bursitis and synovitis, muscular spasm prior to or following surgical procedures, strychnine poisoning, maintenance of muscle relaxation in tetanus, permethrin exposure and organophosphate toxicity.
Horses. Methocarbamol Injection is indicated as an adjunct therapy for acute inflammatory and traumatic conditions of the skeletal muscle, to reduce muscular spasms, and effect striated muscle relaxation. Efficacy of methocarbamol in the treatment of acute muscle hyperactivity secondary to the following conditions has been reported: trauma, muscular and ligamentous sprains and strains, myositis, fibrositis, bursitis and synovitis, tying up syndrome, muscular spasm prior to or following surgical procedures and maintenance of muscle relaxation in tetanus.

Dosage and Admin

Dosage should be based on the severity of the symptoms and resultant therapeutic response. Do not exceed a daily total of 330 mg/kg bodyweight.
Dogs, cats. Administer by slow intravenous injection at a rate of 2 mL/minute. Administer half the dose, pause until animal relaxes, then continue administration to effect. Moderate conditions. 44 mg/kg bodyweight. Severe conditions. 55 to 220 mg/kg bodyweight.
Horses. Administer by intravenous injection only. Dose to effect. In horses, the most effective response is achieved by injecting rapidly through a 15 or 17 gauge needle. Moderate conditions. 4.4 to 22 mg/kg bodyweight. Severe conditions. 22 to 55 mg/kg bodyweight.

CONTRAINDICATIONS

Contraindicated for use in hypersensitivity to the ingredients; in pregnant or lactating animals; and in animals with known or suspected renal pathology.

Downloads